For thousands of years, diseases have been accompanied by the development of human civilization, and among them, tuberculosis is an ancient infectious disease.
As of 2019, an estimated 10 million people worldwide suffer from tuberculosis, and a total of 1.4 million people have died of tuberculosis.
With the emergence of subspecies of combined mycobacteria, the drug resistance of the virus has gradually increased, and the price of drugs has become lower and lower. Therefore, we are facing a new challenge, how to develop new drugs or methods for the treatment of tuberculosis.
Through the continuous efforts of people, in 2019, the new concept of phage therapy has brought people new treatment methods for diseases.At this time the new type of coronavirus pneumonia is also raging around the world.